A Look at Larry Robbins’ Take on the Pharma Industry and Four Picks He Is Bullish On

Page 2 of 2

Another company that Robbins likes among pharmaceuticals is Allergan PLC (NYSE:AGN). The investor praised the company’s decision to sell its generics business and use the proceeds to buy back stock or increase its portfolio of branded products that it could buy at lower prices if the current issues with drug pricing extend across the industry.  At the end of June, Glenview held 1.98 million shares of Allergan PLC (NYSE:AGN). Allergan also ranked as the most popular among the funds we track, being included in 151 equity portfolios.

Follow Allergan Plc (NYSE:AGN)

In the pet care segment, Glenview’s largest holding is represented by VCA Inc (NASDAQ:WOOF), in which it owned 12.80 million shares at the end of June. In August, the fund disclosed cutting the stake to 8.08 million shares, though Robbins has said in the latest letter that he still believes that VCA Inc (NASDAQ:WOOF)’s fundamentals are strong. At the Robin Hood Conference held around a year ago, Robbins pitched VCA as one of his favorite picks.

Follow Vca Inc (NASDAQ:WOOF)

Disclosure: None

Page 2 of 2